Cornea/External Disease News

In this Healio Video Perspective from the World Ophthalmology Congress, John D. Sheppard, MD, MMSc, FACS, of Virginia Eye Consultants discusses Miebo’s efficacy for dry eye disease in various patient subgroups.

In this Healio Video Perspective from the World Ophthalmology Congress, John D. Sheppard, MD, MMSc, FACS, of Virginia Eye Consultants discusses clinical trial data for Miebo for the treatment of dry eye disease.

In this Healio video, Mahnia Madan, OD, FAAO, explains that while many cosmetics are not tested for safety around the eyes, new research shows that three Lumify Eye Illuminations products are both safe and effective for use.

A study covering a large U.S. database over 22 years found a steady decrease in the rate of endophthalmitis after intraocular procedures.

Spencer Trask & Co. announced the launch of Signal12, a clinical-stage dry eye company that plans to advance Pro-ocular for the treatment of dry eye disease, according to a press release.

An AI model was able to identify several common eye diseases in children using cell phone photos that could be taken at home, researchers reported in JAMA Pediatrics.

Eyenovia and SGN Nanopharma have announced a collaboration agreement to develop a new drug-device combination product for chronic dry eye disease.

Patients with dry eye disease experienced improvements in ocular discomfort after treatment with reproxalap, according to a press release from Aldeyra Therapeutics.

Over in my column The Dry Eye, I’ve embarked on a project to look at the basics of diagnosing and treating dry eye disease.

OcuSoft announced the launch of Retaine Allergy, a prescription-strength olopatadine hydrochloride ophthalmic solution 0.2% for eye allergy itch relief.